Advanced Bradycardia Device Feature Utilization and Clinical Outcomes
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 3,389
- 主要终点
- Complication Rate at 1-year Post-implant
研究概览
简要总结
Pacemaker technology is constantly evolving. In the past 10 years, numerous advancements have been made in pacemaker therapy, diagnostics and connectivity. These advancements include automated capture, automated sensing, patient alert functions, algorithms minimizing ventricular pacing, automatic mode switching in response to atrial tachyarrhythmia, rate responsive pacing, advanced diagnostic features, remote monitoring and radiofrequency (RF) technology. However, little information is available on how these new features are being utilized by physicians in the real world and how these features impact patient outcomes.
This observational study will gather data on the patients' presenting clinical status, indication for device implantation, utilization of advanced device features, device therapy choices, clinical management and outcomes in a general pacemaker population.
The primary aim of the study is to evaluate the usage of advanced features and diagnostics in patients with St. Jude Medical pacemakers. The secondary aim of the study is to learn more about the progressive clinical outcomes in the general pacemaker patient population. The tertiary aim of the study is to evaluate the correlation between the usage of advanced features in pacemaker patients and the patient's clinical outcomes.
详细描述
Evaluation of Device Features and Diagnostics
- Programmed parameters: Advanced pacemaker features (Autocapture, Auto sensitivity control (ASC), Ventricular Intrinsic Preference (VIP®), Patient Notifier, RF telemetry, and newer advanced features)
- Device and lead measurements
- Number of AT/AF, VT/VF, PMT and AMS episodes
Evaluation of Clinical Parameters
- Indication for device implantation
- Cardiac and arrhythmia history
- Cardiac drug utilization
- Cardiac events: incidence and onset of symptomatic atrial fibrillation (AF), onset of heart failure (HF), incidence and onset of angina, occurrence of myocardial infarction (MI), occurrence of transient ischemic attack (TIA)/ischemic stroke, and occurrence of hemorrhagic stroke
- Modified Specific Activity Scale (SAS)
- Intrinsic QRS duration
- Left ventricular ejection fraction (LVEF)
- Adverse events
- All-cause, cardiovascular and heart failure hospitalizations
- All-cause, cardiovascular and heart failure mortality
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient has a current indication for a single-chamber (SR) or dual-chamber (DR) pacemaker or CRT-P device.
- •Patient is implanted with an SJM Accent™ SR/DR, Accent™ SR/DR RF, Anthem™ CRT-P, Anthem™ CRT-P RF, or newer SJM pacemaker device.
- •Patient is geographically stable and willing to comply with the required follow-up schedule.
- •Patient is not pregnant or planning to become pregnant.
- •Patient is >18 years of age.
排除标准
- •Patient's life expectancy is less than 12 months.
结局指标
主要结局
Complication Rate at 1-year Post-implant
时间窗: 12 months
Complication rate and 95% confidence interval at 1-year post-implant
次要结局
未报告次要终点